Consistent with the above mentioned, double inhibition of EGFR and MET with AC0010 and crizotinib, respectively, prevented colony formation and suppressed MET activation in resistant cell lines and reduced significantly tumor growth in xenograft, compared with single therapy (86). Here, MET is linked to neoplasm.